Kronos Bio Inc. is a biopharmaceutical company focused on the discovery and development of therapies targeting novel cancer vulnerabilities. With a unique approach that combines deep biological insights and cutting-edge chemistry, Kronos Bio is poised to make a significant impact in the field of oncology.
